Group 1 - The core point of the article is that Chunli Medical (688236.SH) is currently trading at 22.12 yuan, reflecting a decline of 3.24% and is in a state of breaking its initial public offering price [1] - Chunli Medical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 30, 2021, with an initial offering price of 29.81 yuan and issued a total of 38.428 million shares [1] - The total amount raised during the IPO was 1.145 billion yuan, with a net amount of 1.067 billion yuan after deducting issuance costs, which was 932.8717 million yuan less than the originally planned net fundraising amount [1] Group 2 - The company intended to raise 2 billion yuan for various projects, including orthopedic implants and supporting materials, R&D center construction, marketing network development, and working capital [1] - The total issuance costs amounted to 78.4104 million yuan, with Huatai United Securities receiving a sponsorship fee of 1.5 million yuan and underwriting fees of 65.2359 million yuan [1]

中国经济网北京1月30日讯 春立医疗(688236.SH)今日收报23.50元，跌幅6.93%。目前该股处于破 发状态。 春立医疗于2021年12月30日在上交所科创板上市，发行价格为29.81元，发行股份数量3,842.80万 股，保荐机构为华泰联合证券有限责任公司，保荐代表人为张畅、茹涛。 春立医疗上市发行募集资金总额为114,553.87万元，扣除发行费用后募集资金净额为106,712.83万 元，较原拟募集资金净额少93287.17万元。 2021年12月27日，春立医疗发布的招股书显示，公司拟募集资金200,000.00万元，用于骨科植入 物及配套材料综合建设项目、研发中心建设项目、营销网络建设项目、补充流动资金项目。 春立医疗上市发行费用合计7,841.04万元，华泰联合证券有限责任公司获得保荐费用150.00万元、 承销费用6,523.59万元。 (责任编辑：徐自立) ...

中国经济网北京1月8日讯 春立医疗(688236.SH)今日收报25.00元，跌幅2.50%。目前该股处于破发 状态。 春立医疗于2021年12月30日在上交所科创板上市，发行价格为29.81元，发行股份数量3,842.80万 股，保荐机构为华泰联合证券有限责任公司，保荐代表人为张畅、茹涛。 春立医疗上市发行募集资金总额为114,553.87万元，扣除发行费用后募集资金净额为106,712.83万 元，较原拟募集资金净额少93287.17万元。 2021年12月27日，春立医疗发布的招股书显示，公司拟募集资金200,000.00万元，用于骨科植入物 及配套材料综合建设项目、研发中心建设项目、营销网络建设项目、补充流动资金项目。 春立医疗上市发行费用合计7,841.04万元，华泰联合证券有限责任公司获得保荐费用150.00万元、 承销费用6,523.59万元。 (责任编辑：魏京婷) ...